Polygiene AB (POLYG)
Stockholm Exchange · Sweden · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 3.450 |
|---|---|
| 52-week range | 2.980 – 10.800 |
| Return, 1 month / 3 months | −6.3% / −32.6% |
| Return, 1 year / 3 years | −58.7% / −34.8% |
| Trend | Below its 200-day average |
| RSI (14) | 49 |
| Volatility (1 year) | 78.3% |
| Worst drawdown (1 year) | -70.1% |
| Average daily value traded | 0.15M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Polygiene AB is a Swedish company that supplies treatments for textiles and other materials, helping them stay fresher and resist odours and microbes. Its technologies are applied to apparel, footwear, sports gear and home textiles, and are offered to brands and manufacturers that license them for their own products. The company is based in Sweden and works with customers in the clothing and outdoor industries, providing treatments rather than finished goods.
Polygiene AB trades under the code POLYG on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Polygiene AB (POLYG) trades on the Stockholm Exchange in Sweden. It last closed at SEK 3.450 on 20 October 2026.
Its price-based Market X-Ray is 16 out of 100 (a weak price profile), ranking 838 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 58.7% and over the last three months it fell 32.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 9 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -41.3% | ||
| From 52-week high | -66.3% | ||
| Momentum | 9 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -32.6% | ||
| 6-month return | -53.9% | ||
| 12-month return, skipping the last month | -56.0% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 78.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -70.1% | ||
| Liquidity | 34 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.15M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +11.3% |
|---|---|
| 1 month | −6.3% |
| 3 months | −32.6% |
| 6 months | −53.9% |
| 1 year | −58.7% |
| 3 years | −34.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 3.730 / 5.878 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.279 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2025 | SEK 0.1300 |
| 9 May 2025 | SEK 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.